Q2 FY2025 · ended Jun 30, 2025 · Revenue $0 · Filed Aug 13, 2026
Vivani Medical, Inc. (VANI) files with the SEC under industry code 3845, Electromedical & Electrotherapeutic Apparatus. Free cash flow was -$6.1 million. As of Jun 30, 2026 it held $19.9 million in cash and investments and $17.9 million in total debt.
Revenue
$0
Net income
$-6.37M
+10.8% vs year-ago quarter
Operating cash flow
$-6.04M
+0.9% vs year-ago quarter
Free cash flow
$-6.13M
+0.4% vs year-ago quarter
EPS
$-0.07
+41.7% vs year-ago quarter
Dividend per share
None
Shares outstanding
90.20M
+52.3% vs year-ago quarter
Net cash
$2.04M
Q2 FY2026
Operating margin
—
Company profile
- Industry
- Electromedical & Electrotherapeutic Apparatus (SIC 3845)
- Listed as
- VANI (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Alameda, CA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1266806
- Former names
- SECOND SIGHT MEDICAL PRODUCTS INC (until Aug 18, 2022); SECOUND SIGHT MEDICAL PRODUCTS INC (until Oct 10, 2003)
Other Electromedical & Electrotherapeutic Apparatus companies
- Medtronic plc MDT
- LivaNova PLC LIVN
- Integer Holdings Corp ITGR
- Axogen, Inc. AXGN
- TransMedics Group, Inc. TMDX
- CONMED Corp CNMD
- Ceribell, Inc. CBLL
- InMode Ltd. INMD
All 31 Electromedical & Electrotherapeutic Apparatus companies
Key figures
Fiscal-year totals from the annual reports; switch to Annual for the full-year view. Balance sheet lines are as of each year end.
| Line | Q2 FY2026 Jun 30, 2026 |
Q1 FY2026 Mar 31, 2026 |
Q4 FY2025 Dec 31, 2025 |
Q3 FY2025 Sep 30, 2025 |
Q2 FY2025 Jun 30, 2025 |
|---|---|---|---|---|---|
| Revenue | — | — | — | — | $0 |
| Operating income | -$6.9M | -$6.8M | -$6.8M | -$6.7M | -$7.5M |
| Net income | -$6.4M | -$6.8M | -$6.6M | -$6.5M | -$7.1M |
| Diluted EPS | -$0.07 | -$0.08 | -$0.09 | -$0.11 | -$0.12 |
| Operating cash flow | -$6.0M | -$6.2M | -$6.7M | -$6.4M | -$6.1M |
| Free cash flow | -$6.1M | -$6.2M | -$7.0M | -$7.2M | -$6.2M |
| Total assets | $41.6M | $42.4M | $39.4M | $25.0M | $28.9M |
| Total liabilities | $22.7M | $23.3M | $23.7M | $23.7M | $24.0M |
| Stockholders' equity | $19.0M | $19.1M | $15.7M | $1.3M | $4.9M |
| Cash and investments | $19.9M | $19.7M | $16.2M | $2.6M | $6.8M |
| Total debt | $17.9M | $18.3M | $18.9M | $18.3M | $18.6M |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Regulation FD disclosure
|
Oct 30, 2026 | Oct 30, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 29, 2026 | Oct 29, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 16, 2026 | Sep 16, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Aug 17, 2026 | Aug 17, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 13, 2026 | Aug 13, 2026 |
| 10-Q | Quarterly report | Aug 13, 2026 | Jun 30, 2026 |
All 838 Vivani Medical, Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.